🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to make Erwinase available to patients with ac...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00590915
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2000-09
Trial ID
NCT00613457
This trial is evaluating the safety and tolerability of venetoclax with che...
Status
Recruiting
Location
University of California San Francisco-Benioff Children's Hospital
Start Date
2023-03-29
Trial ID
NCT05292664
Primary objective : * To explore the relation between 3 doses of GRASPA an...
Status
Completed
Location
Hopital Debrousse
Start Date
2006-01
Trial ID
NCT00723346
Treatments Being Tested
The primary objective was to evaluate the effect of blinatumomab on overall...
Status
Terminated
Location
Research Site
Start Date
2014-01-03
Trial ID
NCT02013167
Treatments Being Tested
This study will utilize Erwinaze via intravenous administration in patients...
Status
Completed
Location
Children's Hospital of Los Angeles
Start Date
2012-11
Trial ID
NCT01643408
Treatments Being Tested
RATIONALE: L-asparaginase is an important component of treatment for childh...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2005-04
Trial ID
NCT00400946
The main purpose of this study is to find out which form of asparaginase (t...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-02
Trial ID
NCT00187083
Asparaginase is a cornerstone in the treatment of ALL, but its utility is l...
Status
Completed
Location
Hopital Des Enfants Reine Fabiola
Start Date
2009-12
Trial ID
NCT01518517
Treatments Being Tested